RecruitingNot ApplicableNCT05595226
Effect of RT3D-TEE-guided Mitral Valve Repair on Outcomes in Patients With Degenerative Mitral Valve Disease
Sponsor
Sheng Liu
Enrollment
338 participants
Start Date
Dec 31, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of this randomized controlled trial to investigate the effects of Real-time 3D transesophageal echocardiography (RT3D-TEE)-guided mitral valve repair on surgical failure and 1-year reoccurrence of mitral valve regurgitation in patients with degenerative mitral value disease.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria2
- Diagnosed with chronic primary degenerative mitral regurgitation by the preoperative echocardiogram.
- Informed consent was obtained
Exclusion Criteria4
- Re-operation of mitral regurgitation
- Concurrent surgical plan for congenital heart disease, coronary artery bypass grafting, aortic valve surgery, radiofrequency ablation of atrial fibrillation and other cardiac surgeries.
- Mitral valve replacement
- Unable to undergo TEE
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURERT3D-TEE-guided mitral valve repair
RT3D-TEE forms a surgical plan before surgery and 3 to 4 senior doctors with more than 50 cases of mitral valve repair perform the procedure.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05595226